Clinical trial
Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)
NCT00000586 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00000586 |
|---|---|
| Title | Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH) |
| Official title | Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH) |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Sickle Cell, Hematologic Diseases, Hemoglobinopathies |
| Intervention type | Drug |
| Interventions | hydroxyurea |
| Start date | Jan 1, 1992 |
| Primary completion | Jun 1, 1994 |
| Completion | Jun 1, 1994 |
| First posted | Oct 28, 1999 |
| Last update posted | Apr 14, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: